Clinical Trial Update: Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating how microbiome mechanisms influence insulin resistance in humans; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Insulin Sensitivity

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Insulin Sensitivity | Phase 2 | Status: COMPLETED | Results posted: 2020-09-11